Filtros de búsqueda

Lista de obras de Guido Ferrari

A Highly Conserved Residue of the HIV-1 gp120 Inner Domain Is Important for Antibody-Dependent Cellular Cytotoxicity Responses Mediated by Anti-cluster A Antibodies

artículo científico publicado en 2015

A cluster of HIV type 1 subtype C sequences from Ethiopia, observed in full genome analysis, is not sustained in subgenomic regions

artículo científico publicado en 2003

A panel of MHC class I restricted viral peptides for use as a quality control for vaccine trial ELISPOT assays

artículo científico publicado en 2002

A phase I trial of preventive HIV vaccination with heterologous poxviral-vectors containing matching HIV-1 inserts in healthy HIV-uninfected subjects

artículo científico publicado en 2011

A strongly selected mutation in the HIV-1 genome is independent of T cell responses and neutralizing antibodies.

artículo científico publicado en 2017

A trimeric HIV-1 envelope gp120 immunogen induces potent and broad anti-V1V2 loop antibodies against HIV-1 in rabbits and rhesus macaques

artículo científico publicado en 2018

Absence of Immunodominant Anti-Gag p17 (SL9) Responses among Gag CTL-Positive, HIV-Uninfected Vaccine Recipients Expressing the HLA-A*0201 Allele

article

Acute HIV infection: the impact of anti-retroviral treatment on cellular immune responses

artículo científico publicado en 2007

Acute HIV-1 infection in the Southeastern United States: a cohort study

artículo científico publicado en 2012

Adjuvant Dependent Mucosal V2 Responses and RAS Activation in Vaccine Induced Protection from SIVmac251 Acquisition.

artículo científico publicado en 2014

Adjuvant-dependent innate and adaptive immune signatures of risk of SIVmac251 acquisition

artículo científico publicado en 2016

Adjuvanted HIV-1 vaccine promotes antibody-dependent phagocytic responses and protects against heterologous SHIV challenge

artículo científico publicado en 2020

Aggregate complexes of HIV-1 induced by multimeric antibodies

artículo científico publicado en 2014

An Enhanced Synthetic Multiclade DNA Prime Induces Improved Cross-Clade-Reactive Functional Antibodies when Combined with an Adjuvanted Protein Boost in Nonhuman Primates.

artículo científico publicado en 2015

An HIV Envelope gp120-Fc Fusion Protein Elicits Effector Antibody Responses in Rhesus Macaques

artículo científico publicado en 2017

An HIV-1 gp120 envelope human monoclonal antibody that recognizes a C1 conformational epitope mediates potent antibody-dependent cellular cytotoxicity (ADCC) activity and defines a common ADCC epitope in human HIV-1 serum

artículo científico publicado en 2011

Antibodies with high avidity to the gp120 envelope protein in protection from simian immunodeficiency virus SIV(mac251) acquisition in an immunization regimen that mimics the RV-144 Thai trial

artículo científico publicado en 2012

Antibody to the gp120 V1/V2 loops and CD4+ and CD8+ T cell responses in protection from SIVmac251 vaginal acquisition and persistent viremia

artículo científico publicado en 2014

Antibody-dependent cellular cytotoxicity-mediating antibodies from an HIV-1 vaccine efficacy trial target multiple epitopes and preferentially use the VH1 gene family

artículo científico publicado en 2012

Antigen-specific T-cell-mediated immunity after HIV-1 infection: implications for vaccine control of HIV development

artículo científico publicado en 2006

Antiretroviral therapy initiated during acute HIV infection fails to prevent persistent T-cell activation

artículo científico publicado en 2013

Application of area scaling analysis to identify natural killer cell and monocyte involvement in the GranToxiLux antibody dependent cell-mediated cytotoxicity assay.

artículo científico publicado en 2018

Association of HIV-1 Envelope-Specific Breast Milk IgA Responses with Reduced Risk of Postnatal Mother-to-Child Transmission of HIV-1

artículo científico publicado en 2015

Automating Procedures for Processing, Cryopreservation, Storage, and Manipulation of Human Peripheral Blood Mononuclear Cells

Beyond Viral Neutralization

artículo científico publicado en 2017

Boosting of ALVAC-SIV Vaccine-Primed Macaques with the CD4-SIVgp120 Fusion Protein Elicits Antibodies to V2 Associated with a Decreased Risk of SIVmac251 Acquisition

artículo científico publicado en 2016

Boosting of HIV envelope CD4 binding site antibodies with long variable heavy third complementarity determining region in the randomized double blind RV305 HIV-1 vaccine trial.

artículo científico publicado en 2017

Boosting with Subtype C CN54rgp140 Protein Adjuvanted with Glucopyranosyl Lipid Adjuvant after Priming with HIV-DNA and HIV-MVA Is Safe and Enhances Immune Responses: A Phase I Trial

artículo científico publicado en 2016

CD4+CD8+ T cells represent a significant portion of the anti-HIV T cell response to acute HIV infection

artículo científico publicado en 2012

CD8 CTL responses in vaccines: emerging patterns of HLA restriction and epitope recognition

article

CD8+ T cell-mediated suppressive activity inhibits HIV-1 after virus entry with kinetics indicating effects on virus gene expression.

artículo científico publicado en 2000

Characterization of HIV-1 Nucleoside-Modified mRNA Vaccines in Rabbits and Rhesus Macaques

article

Characterization of functional and phenotypic changes in anti-Gag vaccine-induced T cell responses and their role in protection after HIV-1 infection

artículo científico publicado en 2005

Clade B-based HIV-1 vaccines elicit cross-clade cytotoxic T lymphocyte reactivities in uninfected volunteers

artículo científico publicado en 1997

Combined HIV-1 Envelope Systemic and Mucosal Immunization of Lactating Rhesus Monkeys Induces a Robust Immunoglobulin A Isotype B Cell Response in Breast Milk

artículo científico publicado en 2016

Comparative Immunogenicity of HIV-1 gp140 Vaccine Delivered by Parenteral, and Mucosal Routes in Female Volunteers; MUCOVAC2, A Randomized Two Centre Study

artículo científico publicado en 2016

Comparison of systemic and mucosal immunization with helper-dependent adenoviruses for vaccination against mucosal challenge with SHIV.

artículo científico publicado en 2013

Control of Heterologous Simian Immunodeficiency Virus SIV Infection by DNA and Protein Coimmunization Regimens Combined with Different Toll-Like-Receptor-4-Based Adjuvants in Macaques

artículo científico publicado en 2018

Cooperation of B cell lineages in induction of HIV-1-broadly neutralizing antibodies

artículo científico publicado en 2014

Correction for Kibler et al., "Replication-Competent NYVAC-KC Yields Improved Immunogenicity to HIV-1 Antigens in Rhesus Macaques Compared to Nonreplicating NYVAC"

scientific article published on 15 October 2019

Cross-sectional detection of acute HIV infection: timing of transmission, inflammation and antiretroviral therapy

artículo científico publicado en 2011

Crosslinking of a CD4 Mimetic Miniprotein with HIV-1 Env gp140 Alters Kinetics and Specificities of Antibody Responses against HIV-1 Env in Macaques

artículo científico publicado en 2017

DNA-MVA-protein vaccination of rhesus macaques induces HIV-specific immunity in mucosal-associated lymph nodes and functional antibodies

artículo científico publicado en 2017

Defining the risk of SARS-CoV-2 variants on immune protection

artículo científico publicado en 2022

Discriminating between latent and active tuberculosis with multiple biomarker responses.

artículo científico publicado en 2011

Distinct kinetics of Gag-specific CD4+ and CD8+ T cell responses during acute HIV-1 infection

artículo científico publicado en 2012

Diversity of Antiviral IgG Effector Activities Observed in HIV-Infected and Vaccinated Subjects

artículo científico publicado en 2016

Dual-Affinity Re-Targeting proteins direct T cell-mediated cytolysis of latently HIV-infected cells

artículo científico publicado en 2015

Durable HIV-1 antibody and T-cell responses elicited by an adjuvanted multi-protein recombinant vaccine in uninfected human volunteers

artículo científico publicado en 2006

Effect of Highly Active Antiretroviral Therapy and Thymic Transplantation on Immunoreconstitution in HIV Infection

article

Efficacy of NNRTI-based antiretroviral therapy initiated during acute HIV infection

artículo científico publicado en 2011

Ending AIDS as a public health threat by 2030: Scientific Developments from the 2016 INTEREST Conference in Yaoundé, Cameroon.

artículo científico publicado en 2017

Endpoint Assays in HIV-1 Vaccine Trials: Functioning in a Good Laboratory Practices Environment

article

Envelope-specific B-cell populations in African green monkeys chronically infected with simian immunodeficiency virus

artículo científico publicado en 2016

Envelope-specific antibodies and antibody-derived molecules for treating and curing HIV infection

artículo científico publicado en 2016

Epitope specificity of human immunodeficiency virus-1 antibody dependent cellular cytotoxicity [ADCC] responses

artículo científico publicado en 2013

Erratum: Corrigendum: Adjuvant-dependent innate and adaptive immune signatures of risk of SIVmac251 acquisition

artículo científico publicado en 2016

Establishment and maintenance of a PBMC repository for functional cellular studies in support of clinical vaccine trials

artículo científico publicado en 2014

Excellent safety and tolerability of the human immunodeficiency virus type 1 pGA2/JS2 plasmid DNA priming vector vaccine in HIV type 1 uninfected adults

artículo científico publicado en 2006

FCGR2C polymorphisms associate with HIV-1 vaccine protection in RV144 trial

artículo científico publicado en 2014

Fitness costs and diversity of the cytotoxic T lymphocyte (CTL) response determine the rate of CTL escape during acute and chronic phases of HIV infection

artículo científico publicado en 2011

Fixed-dose combination emtricitabine/tenofovir/efavirenz initiated during acute HIV infection; 96-week efficacy and durability.

artículo científico publicado en 2016

Gnidimacrin, a Potent Anti-HIV Diterpene, Can Eliminate Latent HIV-1 Ex Vivo by Activation of Protein Kinase C β.

artículo científico publicado en 2015

HIV antibodies for treatment of HIV infection

artículo científico publicado en 2017

HIV evolution in early infection: selection pressures, patterns of insertion and deletion, and the impact of APOBEC

artículo científico publicado en 2009

HIV-1 Consensus Envelope-Induced Broadly Binding Antibodies

artículo científico publicado en 2017

HIV-1 VACCINES. Diversion of HIV-1 vaccine-induced immunity by gp41-microbiota cross-reactive antibodies

artículo científico publicado en 2015

HIV-1 gp120 and Modified Vaccinia Virus Ankara (MVA) gp140 Boost Immunogens Increase Immunogenicity of a DNA/MVA HIV-1 Vaccine

artículo científico publicado en 2017

HIV-1 gp120 vaccine induces affinity maturation in both new and persistent antibody clonal lineages

artículo científico publicado en 2012

HIV-1 specific IgA Monoclonal Antibodies from an HIV-1 Vaccinee Mediate Galcer Blocking and Phagocytosis

artículo científico publicado en 2018

HIV-1 vaccine-induced C1 and V2 Env-specific antibodies synergize for increased antiviral activities

artículo científico publicado en 2014

HIV-specific functional antibody responses in breast milk mirror those in plasma and are primarily mediated by IgG antibodies

artículo científico publicado en 2011

HIV/AIDS Vaccine Candidates Based on Replication-Competent Recombinant Poxvirus NYVAC-C-KC Expressing Trimeric gp140 and Gag-Derived Virus-Like Particles or Lacking the Viral Molecule B19 That Inhibits Type I Interferon Activate Relevant HIV-1-Speci

artículo científico publicado en 2017

HLA class II genes modulate vaccine-induced antibody responses to affect HIV-1 acquisition

artículo científico publicado en 2015

HLA-A and -B allele expression and ability to develop anti-Gag cross-clade responses in subtype C HIV-1-infected Ethiopians

artículo científico publicado en 2004

Head-to-Head Comparison of Poxvirus NYVAC and ALVAC Vectors Expressing Identical HIV-1 Clade C Immunogens in Prime-Boost Combination with Env Protein in Nonhuman Primates

artículo científico publicado en 2015

Heterogeneous neutralizing antibody and antibody-dependent cell cytotoxicity responses in HIV-1 elite controllers

artículo científico publicado en 2009

High antibody-dependent cellular cytotoxicity responses are correlated with strong CD8 T cell viral suppressive activity but not with B57 status in HIV-1 elite controllers

artículo científico publicado en 2013

High-throughput quantitative analysis of HIV-1 and SIV-specific ADCC-mediating antibody responses

artículo científico publicado en 2011

High‐Dose Recombinant Canarypox Vaccine Expressing HIV‐1 Protein, in Seronegative Human Subjects

article

Human Non-neutralizing HIV-1 Envelope Monoclonal Antibodies Limit the Number of Founder Viruses during SHIV Mucosal Infection in Rhesus Macaques

artículo científico publicado en 2015

Humoral and Innate Antiviral Immunity as Tools to Clear Persistent HIV Infection

artículo científico publicado en 2017

IL-7 enhancement of antigen-driven activation/expansion of HIV-1-specific cytotoxic T lymphocyte precursors (CTLp).

artículo científico publicado en 1995

Identification of effective subdominant anti-HIV-1 CD8+ T cells within entire post-infection and post-vaccination immune responses

artículo científico publicado en 2015

Immune correlates of the Thai RV144 HIV vaccine regimen in South Africa

scientific article published on 01 September 2019

Immune-correlates analysis of an HIV-1 vaccine efficacy trial

artículo científico publicado en 2012

Immunization with an SIV-based IDLV Expressing HIV-1 Env 1086 Clade C Elicits Durable Humoral and Cellular Responses in Rhesus Macaques

artículo científico publicado en 2016

Immunodominance and Cross-Reactivity of B5703-Restricted CD8 T Lymphocytes from HIV Type 1 Subtype C-Infected Ethiopians

article

Immunogenicity of a novel Clade B HIV-1 vaccine combination: Results of phase 1 randomized placebo controlled trial of an HIV-1 GM-CSF-expressing DNA prime with a modified vaccinia Ankara vaccine boost in healthy HIV-1 uninfected adults

artículo científico publicado en 2017

Immunologic and Virologic Mechanisms for Partial Protection from Intravenous Challenge by an Integration-Defective SIV Vaccine

artículo científico publicado en 2017

Immunological and virological mechanisms of vaccine-mediated protection against SIV and HIV.

artículo científico publicado en 2013

Impact of immune escape mutations on HIV-1 fitness in the context of the cognate transmitted/founder genome

artículo científico publicado en 2012

Inclusion of a CRF01_AE HIV envelope protein boost with a DNA/MVA prime-boost vaccine: Impact on humoral and cellular immunogenicity and viral load reduction after SHIV-E challenge

artículo científico publicado en 2012

Increased, durable B-cell and ADCC Responses Associated with T-helper Responses to HIV-1 Envelope in Macaques Vaccinated with gp140 Occluded at the CD4 Receptor Binding Site

artículo científico publicado en 2017

Induction of Heterologous Tier 2 HIV-1-Neutralizing and Cross-Reactive V1/V2-Specific Antibodies in Rabbits by Prime-Boost Immunization

artículo científico publicado en 2016

Induction of plasma (TRAIL), TNFR-2, Fas ligand, and plasma microparticles after human immunodeficiency virus type 1 (HIV-1) transmission: implications for HIV-1 vaccine design

artículo científico publicado en 2008

Infant HIV type 1 gp120 vaccination elicits robust and durable anti-V1V2 immunoglobulin G responses and only rare envelope-specific immunoglobulin A responses

artículo científico publicado en 2014

Infectious virion capture by HIV-1 gp120-specific IgG from RV144 vaccinees

artículo científico publicado en 2013

Initial HIV-1 antigen-specific CD8+ T cells in acute HIV-1 infection inhibit transmitted/founder virus replication

artículo científico publicado en 2012

Innate immune signatures to a partially-efficacious HIV vaccine predict correlates of HIV-1 infection risk

artículo científico publicado en 2021

Interaction with cellular CD4 exposes HIV-1 envelope epitopes targeted by antibody-dependent cell-mediated cytotoxicity

scientific article published on 18 December 2013

Intradermal HIV-1 DNA immunization using needle-free Zetajet<sup>TM</sup> injection followed by HIV-modified vaccinia virus Ankara vaccination is safe and immunogenic in Mozambican young adults: a phase I randomized controlled trial.

artículo científico publicado en 2017

Isolation of HIV-1-neutralizing mucosal monoclonal antibodies from human colostrum

artículo científico publicado en 2012

Lack of infection in HIV-exposed individuals is associated with a strong CD8(+) cell noncytotoxic anti-HIV response

artículo científico publicado en 1999

Leukopak PBMC sample processing for preparing quality control material to support proficiency testing programs

artículo científico publicado en 2014

Lipid nanoparticle encapsulated nucleoside-modified mRNA vaccines elicit polyfunctional HIV-1 antibodies comparable to proteins in nonhuman primates

artículo científico publicado en 2020

Longitudinal Assessment of Immune Response and Viral Characteristics in HIV-Infected Patients with Prolonged CD4+/Viral Load Discordance

article

Loss of DNAM-1 contributes to CD8+ T-cell exhaustion in chronic HIV-1 infection

artículo científico publicado en 2010

Lymph node T cell responses predict the efficacy of live attenuated SIV vaccines

artículo científico publicado en 2012

Massive CD8 T cell response to primary HIV infection in the setting of severe clinical presentation

Maternal HIV-1 Env Vaccination for Systemic and Breast Milk Immunity To Prevent Oral SHIV Acquisition in Infant Macaques.

artículo científico publicado en 2018

Maternal HIV-1 envelope-specific antibody responses and reduced risk of perinatal transmission

artículo científico publicado en 2015

Measurement of cytokine release at the single cell level using the ELISPOT assay

artículo científico publicado en 2006

Mucosal immunization of lactating female rhesus monkeys with a transmitted/founder HIV-1 envelope induces strong Env-specific IgA antibody responses in breast milk

artículo científico publicado en 2013

Naïve T Cells Are Maintained in the Periphery During the First3 Months of Acute HIV-1 Infection: Implications for Analysis of Thymus Function

article

Neutralization Takes Precedence Over IgG or IgA Isotype-related Functions in Mucosal HIV-1 Antibody-mediated Protection

artículo científico publicado en 2016

Neutralizing and other antiviral antibodies in HIV-1 infection and vaccination

artículo científico publicado en 2007

Oligoclonal CD8 lymphocytes from persons with asymptomatic human immunodeficiency virus (HIV) type 1 infection inhibit HIV-1 replication.

artículo científico publicado en 1995

Optimization of storage and shipment of cryopreserved peripheral blood mononuclear cells from HIV-infected and uninfected individuals for ELISPOT assays

artículo científico publicado en 2010

P11-21. Induction of persistent mucosal humoral and cellular responses following immunization of mice with HIV-1 envelope protein in inulin-derived adjuvants

artículo científico publicado en 2009

Pentavalent HIV-1 vaccine protects against simian-human immunodeficiency virus challenge

artículo científico publicado en 2017

Perforin and IL-2 upregulation define qualitative differences among highly functional virus-specific human CD8 T cells

artículo científico publicado en 2010

Performance of serum-supplemented and serum-free media in IFNgamma Elispot Assays for human T cells

artículo científico publicado en 2009

Phase 2 study of an HIV-1 canarypox vaccine (vCP1452) alone and in combination with rgp120: negative results fail to trigger a phase 3 correlates trial

artículo científico publicado en 2007

Phenotypic and functional profile of HIV-inhibitory CD8 T cells elicited by natural infection and heterologous prime/boost vaccination

artículo científico publicado en 2010

Potent functional antibody responses elicited by HIV-I DNA priming and boosting with heterologous HIV-1 recombinant MVA in healthy Tanzanian adults

artículo científico publicado en 2015

Potential To Streamline Heterologous DNA Prime and NYVAC/Protein Boost HIV Vaccine Regimens in Rhesus Macaques by Employing Improved Antigens

artículo científico publicado en 2016

Prevention of infection by a granulocyte-macrophage colony-stimulating factor co-expressing DNA/modified vaccinia Ankara simian immunodeficiency virus vaccine

artículo científico publicado en 2011

Priming with a potent HIV-1 DNA vaccine frames the quality of immune responses prior to a poxvirus and protein boost

article

Proceedings of the Frontiers of Retrovirology Conference 2016.

artículo científico publicado en 2016

Progress in HIV-1 vaccine development.

artículo científico publicado en 2014

Prolonged CD4+ cell/virus load discordance during treatment with protease inhibitor-based highly active antiretroviral therapy: immune response and viral control

artículo científico publicado en 2003

Protection afforded by an HIV vaccine candidate in macaques depends on the dose of SIVmac251 at challenge exposure

artículo científico publicado en 2013

Relationship between functional profile of HIV-1 specific CD8 T cells and epitope variability with the selection of escape mutants in acute HIV-1 infection

artículo científico publicado en 2011

Replication-competent NYVAC-KC yields improved immunogenicity to HIV-1 antigens in rhesus macaques, compared to non-replicating NYVAC

article

Response to Comment on "CD4+CD8+ T Cells Represent a Significant Portion of the Anti-HIV T Cell Response to Acute HIV Infection"

article

Results of an ELISPOT proficiency panel conducted in 11 laboratories participating in international human immunodeficiency virus type 1 vaccine trials

artículo científico publicado en 2005

SIVmac239 MVA vaccine with and without a DNA prime, similar prevention of infection by a repeated dose SIVsmE660 challenge despite different immune responses

artículo científico publicado en 2011

Safety and immunogenicity of a CTL multiepitope peptide vaccine for HIV with or without GM-CSF in a phase I trial

artículo científico publicado en 2008

Safety and immunogenicity of cytotoxic T-lymphocyte poly-epitope, DNA plasmid (EP HIV-1090) vaccine in healthy, human immunodeficiency virus type 1 (HIV-1)-uninfected adults

artículo científico publicado en 2007

Safety, pharmacokinetics, and immunological activities of multiple intravenous or subcutaneous doses of an anti-HIV monoclonal antibody, VRC01, administered to HIV-uninfected adults: Results of a phase 1 randomized trial.

artículo científico publicado en 2017

Strain-Specific V3 and CD4 Binding Site Autologous HIV-1 Neutralizing Antibodies Select Neutralization-Resistant Viruses

artículo científico publicado en 2015

Superiority in Rhesus Macaques of Targeting HIV-1 Env gp140 to CD40 versus LOX-1 in Combination with Replication-Competent NYVAC-KC for Induction of Env-Specific Antibody and T Cell Responses

artículo científico publicado en 2017

Surface expression patterns of negative regulatory molecules identify determinants of virus-specific CD8+ T-cell exhaustion in HIV infection

artículo científico publicado en 2011

T Cell Assays and MIATA: The Essential Minimum for Maximum Impact

Targeting HIV-1 Env gp140 to LOX-1 Elicits Immune Responses in Rhesus Macaques

artículo científico publicado en 2016

Teaching advanced flow cytometry in Africa: 10 years of lessons learned

artículo científico publicado en 2016

The Center for HIV/AIDS Vaccine Immunology (CHAVI) multi-site quality assurance program for cryopreserved human peripheral blood mononuclear cells

artículo científico publicado en 2014

The External Quality Assurance Oversight Laboratory (EQAPOL) proficiency program for IFN-gamma enzyme-linked immunospot (IFN-γ ELISpot) assay

artículo científico publicado en 2014

The first T cell response to transmitted/founder virus contributes to the control of acute viremia in HIV-1 infection

artículo científico publicado en 2009

The function and affinity maturation of HIV-1 gp120-specific monoclonal antibodies derived from colostral B cells

artículo científico publicado en 2015

The human antibody response to the surface of Mycobacterium tuberculosis

artículo científico publicado en 2014

Thinking outside the gate: single-cell assessments in multiple dimensions

artículo científico publicado en 2015

Three-Year Durability of Immune Responses Induced by HIV-DNA and HIV-Modified Vaccinia Virus Ankara and Effect of a Late HIV-Modified Vaccinia Virus Ankara Boost in Tanzanian Volunteers

artículo científico publicado en 2016

Tissue memory B cell repertoire analysis after ALVAC/AIDSVAX B/E gp120 immunization of rhesus macaques

artículo científico publicado en 2016

Toll-like receptor 7/8 (TLR7/8) and TLR9 agonists cooperate to enhance HIV-1 envelope antibody responses in rhesus macaques

scientific article published on 03 January 2014

Transcriptional and posttranscriptional regulation of cytokine gene expression in HIV-1 antigen-specific CD8+ T cells that mediate virus inhibition

artículo científico publicado en 2014

V2-Directed Vaccine-like Antibodies from HIV-1 Infection Identify an Additional K169-Binding Light Chain Motif with Broad ADCC Activity

article

Vaccine Induction of Antibodies against a Structurally Heterogeneous Site of Immune Pressure within HIV-1 Envelope Protein Variable Regions 1 and 2

artículo científico publicado en 2013

Vaccine protection against acquisition of neutralization-resistant SIV challenges in rhesus monkeys

artículo científico publicado en 2012

Vaccine-induced Env V1-V2 IgG3 correlates with lower HIV-1 infection risk and declines soon after vaccination

artículo científico publicado en 2014

Vaccine-induced HIV-1 envelope gp120 constant region 1-specific antibodies expose a CD4-inducible epitope and block the interaction of HIV-1 gp140 with galactosylceramide

artículo científico publicado en 2014

Vaccine-induced plasma IgA specific for the C1 region of the HIV-1 envelope blocks binding and effector function of IgG.

artículo científico publicado en 2013

Variability of the IFN-γ ELISpot assay in the context of proficiency testing and bridging studies

artículo científico publicado en 2016

Vertical T cell immunodominance and epitope entropy determine HIV-1 escape

artículo científico publicado en 2012

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda